CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
Abstract Objective Gastric carcinoma is the most common malignant tumour of the human digestive system worldwide. CD44 serves as a marker for several tumour stem cells, including gastric cancer. However, the prognostic value of CD44 and its correlation with immune infiltration in gastric cancer rema...
Main Authors: | Weiyan Hou, Lingwei Kong, Zhiping Hou, Hairu Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-022-01383-w |
Similar Items
-
CD44 expression is correlated with osteosarcoma cell progression and immune infiltration and affects the Wnt/β-catenin signaling pathway
by: Hairu Ji, et al.
Published: (2023-08-01) -
CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies
by: Min Fang, et al.
Published: (2016-11-01) -
CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
by: Yong Ching-Shya, et al.
Published: (2012-07-01) -
DISC1 as a prognostic biomarker correlated with immune infiltrates in gastric cancer
by: Shiyao Zheng, et al.
Published: (2023-04-01) -
Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
by: Susu Han, et al.
Published: (2019-02-01)